Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


Articles published in Int J Neurosci

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    May 2018
  1. MARKOVA J, Essner U, Akmaz B, Marinelli M, et al
    Sativex(R) as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial.
    Int J Neurosci. 2018 May 24:1-26. doi: 10.1080/00207454.2018.1481066.
    PubMed     Text format     Abstract available


    January 2018
  2. FAHMY EM, Elfayoumy NM, Abdelalim AM, Sharaf SA, et al
    Relation of serum levels of homocysteine, vitamin B12 and folate to cognitive functions in multiple sclerosis patients.
    Int J Neurosci. 2018 Jan 31:1-23. doi: 10.1080/00207454.2018.1435538.
    PubMed     Text format     Abstract available


  3. LI LM, Guo HY, Zhao N, Zhang LJ, et al
    Comparison of olfactory function between neuromyelitis optica and multiple sclerosis.
    Int J Neurosci. 2018 Jan 3:1-21. doi: 10.1080/00207454.2018.1424152.
    PubMed     Text format     Abstract available


    October 2017
  4. ABDOLLAH ZADEH R, Moradi Pordanjani P, Rahmani F, Mashayekhi F, et al
    Association of VDR gene polymorphisms with risk of Relapsing-remitting multiple sclerosis in an Iranian Kurdish population.
    Int J Neurosci. 2017 Oct 26:1-17. doi: 10.1080/00207454.2017.1398158.
    PubMed     Text format     Abstract available


    January 2017
  5. KIM G, Chu R, Yousuf F, Tauhid S, et al
    Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
    Int J Neurosci. 2017 Jan 19:1-34. doi: 10.1080/00207454.2017.1283313.
    PubMed     Text format     Abstract available


    December 2016
  6. DAHDALEH M, Alroughani R, Aljumah M, AlTahan A, et al
    Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?
    Int J Neurosci. 2016 Dec 28:1-16. doi: 10.1080/00207454.2016.1277424.
    PubMed     Text format     Abstract available


  7. LASEK-BAL A, Bartoszek K, Steposz A, Puz P, et al
    Efficacy and safety of mitoxantrone use in primary and secondary progressive multiple sclerosis - study site experience based on the therapy of 104 patients.
    Int J Neurosci. 2016.
    PubMed     Text format     Abstract available


    November 2016
  8. GAO C, Wu L, Chen X, Long Y, et al
    Hypothalamic abnormality in patients with inflammatory demyelinating disorders.
    Int J Neurosci. 2016;126:1036-43.
    PubMed     Text format     Abstract available


    September 2016
  9. JAMROZ-WISNIEWSKA A, Beltowski J, Bartosik-Psujek H, Wojcicka G, et al
    Processes of plasma protein N-homocysteinylation in multiple sclerosis.
    Int J Neurosci. 2016.
    PubMed     Text format     Abstract available


    June 2016
  10. PAKDAMAN H, Harandi AA, Gharagozli K, Abbasi M, et al
    Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta-1a in Iran.
    Int J Neurosci. 2016.
    PubMed     Text format     Abstract available


    May 2016
  11. GIL SANCHEZ A, Lacasa Andrade E, Valls Marsal J, Assens Tauste L, et al
    A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
    Int J Neurosci. 2016.
    PubMed     Text format     Abstract available


  12. KHALID F, Tauhid S, Chua AS, Healy BC, et al
    A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
    Int J Neurosci. 2016.
    PubMed     Text format     Abstract available


    November 2015
  13. SZCZECHOWSKI L, Smilowski M, Helbig G, Krawczyk-Kulis M, et al
    Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Aggressive Multiple Sclerosis - whom, when and how.
    Int J Neurosci. 2015.
    PubMed     Text format     Abstract available


    September 2015
  14. RYAN JJ, Glass Umfleet L, Gontkovsky ST
    Prorating WAIS-IV Summary Scores for Patients with Relapsing-Remitting Multiple Sclerosis.
    Int J Neurosci. 2015.
    PubMed     Text format     Abstract available


  15. TRIANTAFYLLOU N, Thoda P, Armeni E, Rizos D, et al
    Association of sex hormones and glucose metabolism with the severity of multiple sclerosis.
    Int J Neurosci. 2015.
    PubMed     Text format     Abstract available


    May 2015
  16. DEMIRCI S, Demirci S, Kutluhan S, Koyuncuoglu HR, et al
    The Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Multiple Sclerosis.
    Int J Neurosci. 2015.
    PubMed     Text format     Abstract available


  17. HUANG J, Yang Y, Zhou F, Liang Z, et al
    Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
    Int J Neurosci. 2015.
    PubMed     Text format     Abstract available


  18. PIERZCHALA K, Adamczyk-Sowa M, Dobrakowski P, Kubicka-Baczyk K, et al
    Demographic characteristics of MS patients in Poland's upper Silesia region.
    Int J Neurosci. 2015;125:344-51.
    PubMed     Text format     Abstract available


    February 2015
  19. ALVARENGA-FILHO H, Papais-Alvarenga RM, Carvalho SR, Clemente HN, et al
    Does fatigue occur in MS patients without disability?
    Int J Neurosci. 2015;125:107-15.
    PubMed     Text format     Abstract available


    January 2015
  20. MARGARITELLA N, Mendozzi L, Garegnani M, Nemni R, et al
    The EP-score to assess treatment efficacy in RRMS patients: a preliminary study.
    Int J Neurosci. 2015;125:38-42.
    PubMed     Text format     Abstract available


  21. COLPAK AI, Kurne AT, Oguz KK, Has AC, et al
    White matter involvement beyond the optic nerves in CRION as assessed by diffusion tensor imaging.
    Int J Neurosci. 2015;125:10-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: